Literature DB >> 16505830

Defining the clinical role of pharmacogenetics in antiepileptic drug therapy.

D J Dlugos1, R J Buono, T N Ferraro.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16505830     DOI： 10.1038/sj.tpj.6500379

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN： 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  2 in total

1.  Evaluating the Role of Genetic Variants on first-line antiepileptic drug response in North India: Significance of SCN1A and GABRA1 Gene Variants in Phenytoin Monotherapy and its Serum Drug Levels.

Authors:  Ruchi Baghel; Sandeep Grover; Harpreet Kaur; Ajay Jajodia; Chitra Rawat; Ankit Srivastava; Suman Kushwaha; Rachna Agarwal; Sangeeta Sharma; Ritushree Kukreti
Journal:  CNS Neurosci Ther       Date:  2016-06-01       Impact factor: 5.243

2.  Epilepsy Research in Mali: A Pilot Pharmacokinetics Study on First-Line Antiepileptic Drug Treatment.

Authors:  Modibo Sangare; Fatoumata Doumbia; Oumar Sidibe; Aboucacar Alassane Oumar; Sekou Bah; Modibo Kouyate; Seidina S Diakite; Karim Traore; Adama Karembe; Mohamed S Haidara; Souleymane P Coulibaly; Souleymane Coulibaly; Arouna Togora; Housseini Dolo; Drissa Traore; Seydou Doumbia; Mahamadou Diakite; Youssoufa Maiga; Amadou Diawara; Callixte Kuate; Hyung-Goo Kim; Gordon A Awandare
Journal:  J Epilepsy Res       Date:  2020-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.